These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 23230437)

  • 1. Annexin A1 and the regulation of innate and adaptive immunity.
    Gavins FN; Hickey MJ
    Front Immunol; 2012; 3():354. PubMed ID: 23230437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 and resolution of inflammation: tissue repairing properties and signalling signature.
    Gobbetti T; Cooray SN
    Biol Chem; 2016 Oct; 397(10):981-93. PubMed ID: 27447237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.
    Perretti M; Dalli J
    Br J Pharmacol; 2009 Oct; 158(4):936-46. PubMed ID: 19845684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury.
    Ansari J; Kaur G; Gavins FNE
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel aspects of annexin 1 and glucocorticoid biology: intersection with nitric oxide and the lipoxin receptor.
    Perretti M; D'Acquisto F
    Inflamm Allergy Drug Targets; 2006 Apr; 5(2):107-14. PubMed ID: 16613569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
    Vital SA; Becker F; Holloway PM; Russell J; Perretti M; Granger DN; Gavins FN
    Circulation; 2016 May; 133(22):2169-79. PubMed ID: 27154726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac
    Qin CX; Rosli S; Deo M; Cao N; Walsh J; Tate M; Alexander AE; Donner D; Horlock D; Li R; Kiriazis H; Lee MKS; Bourke JE; Yang Y; Murphy AJ; Du XJ; Gao XM; Ritchie RH
    Front Pharmacol; 2019; 10():269. PubMed ID: 31001111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity is a key factor for the resolution of inflammation in asthma.
    Barnig C; Levy BD
    Eur Respir Rev; 2015 Mar; 24(135):141-53. PubMed ID: 25726564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation.
    Perretti M; Dalli J
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():449-469. PubMed ID: 36151051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A twist in anti-inflammation: annexin 1 acts via the lipoxin A4 receptor.
    Gavins FN; Sawmynaden P; Chatterjee BE; Perretti M
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):211-9. PubMed ID: 15982865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective potential of annexin-A1 mimetics in myocardial infarction.
    Qin C; Yang YH; May L; Gao X; Stewart AG; Tu Y; Woodman OL; Ritchie RH
    Pharmacol Ther; 2015 Apr; 148():47-65. PubMed ID: 25460034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology.
    Perretti M; Godson C
    Br J Pharmacol; 2020 Oct; 177(20):4595-4600. PubMed ID: 32954491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin-A1: Therapeutic Potential in Microvascular Disease.
    Purvis GSD; Solito E; Thiemermann C
    Front Immunol; 2019; 10():938. PubMed ID: 31114582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation.
    Vital SA; Senchenkova EY; Ansari J; Gavins FNE
    Cells; 2020 Nov; 9(11):. PubMed ID: 33202930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice.
    Souza DG; Fagundes CT; Amaral FA; Cisalpino D; Sousa LP; Vieira AT; Pinho V; Nicoli JR; Vieira LQ; Fierro IM; Teixeira MM
    J Immunol; 2007 Dec; 179(12):8533-43. PubMed ID: 18056401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation.
    El Kebir D; József L; Filep JG
    J Leukoc Biol; 2008 Sep; 84(3):600-6. PubMed ID: 18495783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FPR2/ALXR agonists and the resolution of inflammation.
    Corminboeuf O; Leroy X
    J Med Chem; 2015 Jan; 58(2):537-59. PubMed ID: 25365541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair.
    Dakin SG; Werling D; Hibbert A; Abayasekara DR; Young NJ; Smith RK; Dudhia J
    PLoS One; 2012; 7(2):e32333. PubMed ID: 22384219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.